On the public citation graph
Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)
0 signed · 168 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2012.144878openalex-snapshot
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
inferredcites →https://doi.org/10.1002/hep.20933openalex-snapshot
Management of Hepatocellular Carcinoma *
inferredcites →https://doi.org/10.1002/hep.21176openalex-snapshot
The natural history of compensated cirrhosis due to hepatitis C virus
inferredcites →https://doi.org/10.1002/hep.21826openalex-snapshot
Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: A seventeen-year prospective cohort study
inferredcites →https://doi.org/10.1002/hep.23340openalex-snapshot
Efficacy and Safety of Peginterferon Alfa-2A (40Kd) Plus Ribavirin in Hepatitis C Patients With Advanced Fibrosis and Cirrhosis
inferredcites →https://doi.org/10.1002/hep.23615openalex-snapshot
Use of Surveillance for Hepatocellular Carcinoma Among Patients With Cirrhosis in the United States
inferredcites →https://doi.org/10.1002/hep.24199openalex-snapshot
Management of Hepatocellular Carcinoma: An Update Δσ
inferredcites →https://doi.org/10.1002/hep.24545openalex-snapshot
Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
inferredcites →https://doi.org/10.1002/hep.24794openalex-snapshot
Family history of liver cancer and hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/hep.26180openalex-snapshot
Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
inferredcites →https://doi.org/10.1002/hep.26301openalex-snapshot
Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis
inferredcites →https://doi.org/10.1002/hep.27288openalex-snapshot
Earlier presentation and application of curative treatments in hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/hep.27598openalex-snapshot
The clinical course of cirrhosis: The importance of multistate models and competing risks analysis
inferredcites →https://doi.org/10.1002/lt.20034openalex-snapshot
The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.jhep.2010.05.004openalex-snapshot
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis
inferredcites →https://doi.org/10.1016/j.jhep.2010.06.004openalex-snapshot
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension
inferredcites →https://doi.org/10.1016/j.jhep.2012.02.010openalex-snapshot
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
inferredcites →https://doi.org/10.1016/j.jhep.2014.01.024openalex-snapshot
Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
inferredcites →https://doi.org/10.1016/s0002-9270(99)00433-5openalex-snapshot
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
inferredcites →https://doi.org/10.1016/s0140-6736(05)67402-8openalex-snapshot
The metabolic syndrome—a new worldwide definition
inferredcites →https://doi.org/10.1016/s0140-6736(06)67924-5openalex-snapshot
Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data
inferredcites →https://doi.org/10.1016/s0168-8278(12)60010-5openalex-snapshot
Antiviral strategies in hepatitis C virus infection
inferredcites →https://doi.org/10.1053/j.gastro.2004.09.014openalex-snapshot
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
inferredcites →https://doi.org/10.1053/j.gastro.2011.12.061openalex-snapshot
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1053/j.gastro.2013.09.019openalex-snapshot
Development and Validation of a Comorbidity Scoring System for Patients With Cirrhosis
inferredcites →https://doi.org/10.1056/nejmoa033364openalex-snapshot
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
inferredcites →https://doi.org/10.1056/nejmoa1402869openalex-snapshot
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
inferredcites →https://doi.org/10.1371/journal.pmed.1001624openalex-snapshot
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4893547openalex-extracted
Prevalence and Risk Factors Associated with Hepatitis C Virus Infection in Patients with Type 2-Diabetes Mellitus; Case Control Study in Lahore, Pakistan
inferred← citeshttps://doi.org/10.1002/9781119756422.ch16openalex-snapshot
Screening, Surveillance, and Prevention of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.6825openalex-snapshot
Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA‐II), serum a‐fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non‐diagnostic serum a‐fetoprotein levels
inferred← citeshttps://doi.org/10.1002/hep.28702openalex-snapshot
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)
inferred← citeshttps://doi.org/10.1002/hep.28961openalex-snapshot
Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States
inferred← citeshttps://doi.org/10.1002/hep.29315openalex-snapshot
Modeling the benefits and harms of surveillance for hepatocellular carcinoma: Information to support informed choices
inferred← citeshttps://doi.org/10.1002/hep.29927openalex-snapshot
Influence of Progenitor‐Derived Regeneration Markers on Hepatitis C Virus–Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort)
inferred← citeshttps://doi.org/10.1002/hep.30034openalex-snapshot
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication
inferred← citeshttps://doi.org/10.1002/hep.30400openalex-snapshot
Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co‐infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End‐Stage Liver Disease as Compared to HCV Mono‐infected Patients
inferred← citeshttps://doi.org/10.1002/hep4.2059openalex-snapshot
Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer‐specific and overall mortality: A modeling approach
inferred← citeshttps://doi.org/10.1002/ird3.13openalex-snapshot
Correlations behind macrotrabecular‐massive and vessels encapsulating tumor cluster patterns in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/16833_2024_261openalex-snapshot
The Evolving Role of Transplant Oncology
inferred← citeshttps://doi.org/10.1007/978-3-319-34214-6_22openalex-snapshot
Surveillance for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-981-96-3894-9_2openalex-snapshot
Hepatocellular Carcinoma Epidemiology
inferred← citeshttps://doi.org/10.1007/s12072-016-9736-3openalex-snapshot
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing
inferred← citeshttps://doi.org/10.1007/s12664-024-01646-7openalex-snapshot
Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma—A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/b978-0-443-21938-2.00020-5openalex-snapshot
Hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.ahj.2017.10.024openalex-snapshot
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients
inferred← citeshttps://doi.org/10.1016/j.banm.2020.06.016openalex-snapshot
Vaccin contre l’hépatite C : intérêt et stratégies utilisées pour les candidats vaccins
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.117508openalex-snapshot
The Wnt signaling pathway in hepatocellular carcinoma: Regulatory mechanisms and therapeutic prospects
inferred← citeshttps://doi.org/10.1016/j.clinre.2019.11.005openalex-snapshot
Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis
inferred← citeshttps://doi.org/10.1016/j.clinre.2020.11.008openalex-snapshot
Treatment of hepatitis C virus infection
inferred← citeshttps://doi.org/10.1016/j.clinre.2021.101771openalex-snapshot
Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus
inferred← citeshttps://doi.org/10.1016/j.ejrad.2023.111266openalex-snapshot
Safety evaluation of combination treatment of drug-eluting bead transarterial chemoembolization and immune checkpoint inhibitors for hepatocellular carcinoma: An increased risk of liver abscess with treatment interval less than one month
inferred← citeshttps://doi.org/10.1016/j.iliver.2022.04.002openalex-snapshot
Liver transplantation for malignant liver tumors
inferred← citeshttps://doi.org/10.1016/j.jhep.2015.01.035openalex-snapshot
Jean-Claude Trinchet (1951–2014)
inferred← citeshttps://doi.org/10.1016/j.jhep.2016.04.031openalex-snapshot
Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis: A prospective study
inferred← citeshttps://doi.org/10.1016/j.jhep.2016.05.045openalex-snapshot
Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts
inferred← citeshttps://doi.org/10.1016/j.jhep.2016.10.031openalex-snapshot
Prognosis of patients with chronic hepatitis B in France (2008–2013): A nationwide, observational and hospital-based study
inferred← citeshttps://doi.org/10.1016/j.jhep.2018.01.031openalex-snapshot
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population
inferred← citeshttps://doi.org/10.1016/j.jhep.2018.07.022openalex-snapshot
Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis
inferred← citeshttps://doi.org/10.1016/j.jhep.2019.01.005openalex-snapshot
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules
inferred← citeshttps://doi.org/10.1016/j.jhep.2020.05.052openalex-snapshot
Personalized surveillance for hepatocellular carcinoma in cirrhosis – using machine learning adapted to HCV status
inferred← citeshttps://doi.org/10.1016/j.jhep.2020.11.023openalex-snapshot
Screening is associated with a lower risk of hepatocellular carcinoma-related mortality in patients with chronic hepatitis B
inferred← citeshttps://doi.org/10.1016/j.jhep.2021.04.022openalex-snapshot
Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis
inferred← citeshttps://doi.org/10.1016/j.jhep.2022.11.003openalex-snapshot
Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis
inferred← citeshttps://doi.org/10.1016/j.jhep.2024.03.048openalex-snapshot
Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC
inferred← citeshttps://doi.org/10.1016/j.jhep.2024.12.030openalex-snapshot
Differences between hepatocellular carcinoma caused by alcohol and other aetiologies
inferred← citeshttps://doi.org/10.1016/j.jhep.2025.02.008openalex-snapshot
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis
inferred← citeshttps://doi.org/10.1016/j.jhepr.2019.11.001openalex-snapshot
Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication
inferred← citeshttps://doi.org/10.1016/j.jhepr.2021.100285openalex-snapshot
Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance
inferred← citeshttps://doi.org/10.1016/j.jhepr.2021.100390openalex-snapshot
Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis
inferred← citeshttps://doi.org/10.1016/j.jhepr.2025.101355openalex-snapshot
Associations between fruit and vegetable consumption and HCC occurrence in patients with cirrhosis
inferred← citeshttps://doi.org/10.1016/j.jhepr.2026.101740openalex-snapshot
Comparative evaluation of regression and machine-learning models for hepatocellular carcinoma risk stratification across diverse aetiologies
inferred← citeshttps://doi.org/10.1016/j.lpm.2016.11.006openalex-snapshot
Le dépistage du carcinome hépatocellulaire
inferred← citeshttps://doi.org/10.1016/j.lpm.2019.01.001openalex-snapshot
Virus de l’hépatite C : une élimination programmable
inferred← citeshttps://doi.org/10.1016/j.med.2025.01.014openalex-snapshot
Protocolo de diagnóstico y tratamiento del hepatocarcinoma
inferred← citeshttps://doi.org/10.1016/j.micinf.2019.06.008openalex-snapshot
The remarkable history of the hepatitis C virus
inferred← citeshttps://doi.org/10.1016/j.nanoso.2024.101342openalex-snapshot
Upgraded theragnostic strategies of multivariate nano gold in the management of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.psychres.2019.112597openalex-snapshot
Paliperidone is associated with reduced risk of severe hepatic outcome in patients with schizophrenia and viral hepatitis: A nationwide population-based cohort study
inferred← citeshttps://doi.org/10.1016/s0140-6736(18)31875-0openalex-snapshot
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
inferred← citeshttps://doi.org/10.1016/s0140-6736(18)32111-1openalex-snapshot
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
inferred← citeshttps://doi.org/10.1016/s1155-1976(17)80162-5openalex-snapshot
10.1016/s1155-1976(17)80162-5
inferred← citeshttps://doi.org/10.1016/s1155-1976(20)43227-9openalex-snapshot
10.1016/s1155-1976(20)43227-9
inferred← citeshttps://doi.org/10.1016/s1166-8598(21)44957-4openalex-snapshot
10.1016/s1166-8598(21)44957-4
inferred← citeshttps://doi.org/10.1016/s1470-2045(15)00014-5openalex-snapshot
Hepatocellular carcinoma surveillance with miRNAs
inferred← citeshttps://doi.org/10.1016/s2468-1253(16)30002-4openalex-snapshot
Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial
inferred← citeshttps://doi.org/10.1016/s2468-1253(26)00217-7openalex-snapshot
Genetic variants and the risk of renal impairment in decompensated cirrhosis: a multi-ancestry genome-wide association study
inferred← citeshttps://doi.org/10.1021/acs.jafc.4c03340openalex-snapshot
Inhibition of Macrophage Pyroptosis─A New Therapeutic Strategy to Alleviate T-2 Toxin-Induced Subacute Liver Injury by Directly Competing with the Key Target
inferred← citeshttps://doi.org/10.1038/nrgastro.2016.176openalex-snapshot
Global epidemiology and burden of HCV infection and HCV-related disease
inferred← citeshttps://doi.org/10.1038/onc.2017.271openalex-snapshot
Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus
inferred← citeshttps://doi.org/10.1038/s41435-019-0066-zopenalex-snapshot
The remarkable history of the hepatitis C virus
inferred← citeshttps://doi.org/10.1038/s41575-019-0165-3openalex-snapshot
The role of telomeres and telomerase in cirrhosis and liver cancer
inferred← citeshttps://doi.org/10.1038/s41581-018-0081-8openalex-snapshot
Hepatitis C virus and the kidney
inferred← citeshttps://doi.org/10.1038/s41598-022-15928-7openalex-snapshot
First identification of bovine hepacivirus in wild boars
inferred← citeshttps://doi.org/10.1038/s41684-026-01724-7openalex-snapshot
Multiomics characterization of an alcohol-induced hepatocellular carcinoma mouse model
inferred← citeshttps://doi.org/10.1053/j.gastro.2016.09.009openalex-snapshot
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
inferred← citeshttps://doi.org/10.1053/j.gastro.2018.04.027openalex-snapshot
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study
inferred← citeshttps://doi.org/10.1053/j.gastro.2018.07.015openalex-snapshot
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs
inferred← citeshttps://doi.org/10.1055/s-0037-1601349openalex-snapshot
Liver Cancer Emergence Associated with Antiviral Treatment: An Immune Surveillance Failure?
inferred← citeshttps://doi.org/10.1080/00365513.2023.2175327openalex-snapshot
Utility of comet assay of DNA damage in the detection of malignant transformation of chronic liver cirrhosis
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000618openalex-snapshot
Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical application
inferred← citeshttps://doi.org/10.1097/hep.0000000000000615openalex-snapshot
The clinical and financial burden of nonhepatocellular carcinoma focal lesions detected during the surveillance of patients with cirrhosis
inferred← citeshttps://doi.org/10.1097/hep.0000000000000893openalex-snapshot
ER stress signaling at the interphase between MASH and HCC
inferred← citeshttps://doi.org/10.1097/mcg.0000000000001039openalex-snapshot
Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis
inferred← citeshttps://doi.org/10.1111/apt.13722openalex-snapshot
The relationship between liver stiffness measurement and outcome in patients with chronic hepatitis C and cirrhosis: a retrospective longitudinal hospital study
inferred← citeshttps://doi.org/10.1111/apt.14341openalex-snapshot
Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis
inferred← citeshttps://doi.org/10.1111/jgh.13670openalex-snapshot
Diabetes, hepatocellular carcinoma, and mortality in hepatitis C‐infected patients: A population‐based cohort study
inferred← citeshttps://doi.org/10.1111/joim.13463openalex-snapshot
Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals
inferred← citeshttps://doi.org/10.1111/jvh.12823openalex-snapshot
The benefits of hepatitis C virus cure: Every rose has thorns
inferred← citeshttps://doi.org/10.1111/jvh.13029openalex-snapshot
Non‐virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO 12 CirVir cohort
inferred← citeshttps://doi.org/10.1111/jvh.13830openalex-snapshot
Dynamic personalized prediction of the individual liver‐related risk after sustained viral response in HCV patients
inferred← citeshttps://doi.org/10.1111/jvh.70079openalex-snapshot
Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B Cure
inferred← citeshttps://doi.org/10.1111/liv.13156openalex-snapshot
Impact of virus eradication in patients with compensated hepatitis C virus‐related cirrhosis: competing risks and multistate model
inferred← citeshttps://doi.org/10.1111/liv.13321openalex-snapshot
The impact of direct antiviral agents on the development and recurrence of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1111/liv.13456openalex-snapshot
Direct‐acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C
inferred← citeshttps://doi.org/10.1111/liv.13921openalex-snapshot
Prognostic factors of survival in HIV / HCV co‐infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort
inferred← citeshttps://doi.org/10.1111/liv.14029openalex-snapshot
Direct‐acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic?
inferred← citeshttps://doi.org/10.1111/liv.14363openalex-snapshot
Micro‐elimination of hepatitis C virus
inferred← citeshttps://doi.org/10.1111/liv.15159openalex-snapshot
ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts
inferred← citeshttps://doi.org/10.1111/liv.16103openalex-snapshot
Integrating PNPLA3 into clinical risk prediction
inferred← citeshttps://doi.org/10.1136/bmjopen-2023-083701openalex-snapshot
Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer
inferred← citeshttps://doi.org/10.1136/gutjnl-2015-310275openalex-snapshot
Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)
inferred← citeshttps://doi.org/10.1136/gutjnl-2023-331695openalex-snapshot
British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-16-1500openalex-snapshot
A Glycomics-Based Test Predicts the Development of Hepatocellular Carcinoma in Cirrhosis
inferred← citeshttps://doi.org/10.1158/1940-6207.c.6547381.v1openalex-snapshot
Data from HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative Management
inferred← citeshttps://doi.org/10.1158/1940-6207.capr-20-0465openalex-snapshot
HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative Management
inferred← citeshttps://doi.org/10.1159/000540438openalex-snapshot
Changes in Mutations of Cell-Free DNA and Liver Tumor Tissue in Patients with Advanced Hepatocellular Carcinoma before and after Introduction of Lenvatinib
inferred← citeshttps://doi.org/10.1186/s12876-022-02496-3openalex-snapshot
Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1186/s44263-025-00173-7openalex-snapshot
Mortality risk in migrant and non-migrant individuals with chronic hepatitis B virus infection: a French hospital-based cohort study (ANRS CO22 HEPATHER)
inferred← citeshttps://doi.org/10.14218/jcth.2023.00040openalex-snapshot
Liquid Liver Biopsy for Disease Diagnosis and Prognosis
inferred← citeshttps://doi.org/10.14309/ajg.0000000000000715openalex-snapshot
Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms
inferred← citeshttps://doi.org/10.1684/ecn.2018.0413openalex-snapshot
Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosis
inferred← citeshttps://doi.org/10.17235/reed.2015.4012/2015openalex-snapshot
New challenges in clinical research on hepatocellular carcinoma
inferred← citeshttps://doi.org/10.20517/mtod.2022.38openalex-snapshot
Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1394843/v1openalex-snapshot
An Anoikis-related Gene Signature for Forecasting Prognosis, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.21203/rs.3.rs-4530115/v1openalex-snapshot
Bioinformatics and Genetic Correlation Studies of Functional Gene Partners of Tp53 Gene Associated With Hepatocellular Carcinoma and Liver Cirrhosis Among Patients in Ucth, Calabar
inferred← citeshttps://doi.org/10.2147/dmso.s367483openalex-snapshot
Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.2147/jhc.s159581openalex-snapshot
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms
inferred← citeshttps://doi.org/10.2174/9798898813369126010008openalex-snapshot
Beneficial Effect of Nutraceuticals on Liver Diseases
inferred← citeshttps://doi.org/10.2196/89577openalex-snapshot
RESONANCE: Protocol for a Nationwide Cohort Study of Chronic Liver Diseases Using the French National Health Data System
inferred← citeshttps://doi.org/10.24060/2076-3093-2022-12-2-139-150openalex-snapshot
Hepatocellular Carcinoma: Aetiology and Mechanisms of Development. A Literature Review
inferred← citeshttps://doi.org/10.26442/00403660.2019.02.000082openalex-snapshot
Risk factors of unfavorable prognosis of chronic hepatitis C
inferred← citeshttps://doi.org/10.31482/mmsl.2022.046openalex-snapshot
LABORATORY DIAGNOSIS OF HEPATOCELLULAR CARCINOMA - CONVENTIONAL BIOMARKERS AND BLOOD PLASMA SPECTROSCOPY
inferred← citeshttps://doi.org/10.3322/caac.70018openalex-snapshot
Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians
inferred← citeshttps://doi.org/10.3350/cmh.2016.0054openalex-snapshot
Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
inferred← citeshttps://doi.org/10.3389/fphar.2022.838079openalex-snapshot
Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies
inferred← citeshttps://doi.org/10.3389/fphar.2023.1326346openalex-snapshot
Iberverin exhibits antineoplastic activities against human hepatocellular carcinoma via DNA damage-mediated cell cycle arrest and mitochondrial-related apoptosis
inferred← citeshttps://doi.org/10.3390/cancers13205180openalex-snapshot
Involvement of Kynurenine Pathway in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/cells9061370openalex-snapshot
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
inferred← citeshttps://doi.org/10.3390/diseases13070207openalex-snapshot
Hepatocellular Carcinoma: A Comprehensive Review
inferred← citeshttps://doi.org/10.3390/ijms232213834openalex-snapshot
Anticarcinogenic Effects of Isothiocyanates on Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/jcm10020353openalex-snapshot
Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
inferred← citeshttps://doi.org/10.3390/microorganisms12091926openalex-snapshot
Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals
inferred← citeshttps://doi.org/10.3390/nu10010060openalex-snapshot
Eating Patterns in Patients with Compensated Cirrhosis: A Case-Control Study
inferred← citeshttps://doi.org/10.3390/pathogens10111366openalex-snapshot
Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
inferred← citeshttps://doi.org/10.3748/wjg.v31.i40.111727openalex-snapshot
Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.3851/imp3077openalex-snapshot
Why is Viral Eradication so Important in Patients with HCV-Related Cirrhosis?
inferred← citeshttps://doi.org/10.4103/jgid.jgid_211_23openalex-snapshot
Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma: Systematic Review and Meta-analysis
inferred← citeshttps://doi.org/10.4414/smw.2015.14231openalex-snapshot
Screening for liver cancer in high risk patients in Switzerland: Yes, it works, but No, we do not do it systematically!
inferred← citeshttps://doi.org/10.6084/m9.figshare.21202032openalex-snapshot
Additional file 1 of Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma
inferred← citeshttps://doi.org/10.6084/m9.figshare.21202035openalex-snapshot
Additional file 2 of Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma
inferred← citeshttps://doi.org/10.70675/780d49f6zde47z4ff1z9bc4z7e014070104copenalex-snapshot
Développement d'une stratégie Cheval de Troie dans le traitement du carcinome hépatocellulaire
inferred← citeshttps://doi.org/10.70675/821ba15dz5e53z43e6zbe54zf564001c002eopenalex-snapshot
Integrated immunogenomic analysis exploring tumor heterogeneity and evolution of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.70675/cf105f73z806bz4694z95caz032fec1647efopenalex-snapshot
Trajectoires de santé des patients avec carcinome hépatocellulaire : apport des bases de données de santé
inferred← citeshttps://doi.org/10.70675/f74abe25z2801z481cza9b8zb9232964c1faopenalex-snapshot
The functional role of Claudin-1 as a mediator and therapeutic target in liver fibrogenesis and hepatocarcinogenesis
inferred← citeshttps://doi.org/10.7507/1001-5515.201610046openalex-snapshot
[Research and application of 18F-fluorodeoxyglucose positron emission tomography/ computed tomography for the diagnosis and treatment of primary hepatocellular carcinoma].
inferred← citeshttps://doi.org/10.7861/clinmedicine.18-2-s66openalex-snapshot
Surveillance for hepatocellular cancer
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.